Rundu Pharma
00292310.351.77% ( +0.18 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Rundu Pharma(002923) the Revenue is 348.71 M (+36.91%);the EBIT is 28.89 M (+103.1%);the EPS is 0.05 (+400%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.35B36.91%
----
----
EBIT
0.03B103.09%
----
----
EPS
0.05400.00%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf